{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:49:31Z","timestamp":1786988971779,"version":"build-2736575974"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["smoa.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Before dapoxetine was approved for the treatment of lifelong premature ejaculation (LPE) in China, daily dosing with off-label sertraline was common.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate the efficacy of dapoxetine in the treatment of patients with LPE as an alternative to sertraline therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective study included LPE patients who previously attempted treatment with sertraline and who agree to receive dapoxetine therapy in our hospital from January 2020 to March 2021. Patients who received any PE therapy in the two months prior to the dapoxetine therapy were excluded. All patients received dapoxetine 30 mg (taken 1\u20133 hours before sexual intercourse) for 12 weeks, and they were not taking sertraline during the trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measure<\/jats:title>\n                    <jats:p>Data on their intravaginal ejaculatory latency time and premature ejaculation profile were recorded before and after the dapoxetine treatment. Clinical Global Impression of Change scores and data on Treatment-Emergent adverse events were collected after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 144 patients with LPE completed this study; including 64 patients who reported that previous sertraline treatment was satisfactory (group A) and 80 patients for whom previous sertraline therapy was unsatisfactory in treating PE (group B). Both groups experienced significantly increased intravaginal ejaculatory latency time. Dapoxetine therapy was reported satisfactory by 67.5% of patients with LPE in whom sertraline therapy unsatisfactory according to their Clinical Global Impression of Change score, which was not different from those who reported this result in group A (62.5%). Similar outcomes were also reported for premature ejaculation profile and treatment-emergent adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>: Although both dapoxetine and sertraline are selective serotonin re-uptake inhibitors, dapoxetine therapy is satisfactory in 67.5% of patients with LPE in whom sertraline treatment unsatisfactory, and the effect of dapoxetine was independent of the effect of sertraline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.esxm.2021.100473","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T18:54:49Z","timestamp":1640631289000},"page":"100473-1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Dapoxetine in the Treatment of Patients With Lifelong Premature Ejaculation as an Alternative to Sertraline Therapy"],"prefix":"10.1093","volume":"10","author":[{"given":"Guoxiong","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Urology \u00a0 , Shaanxi, Xian , P.R. China"},{"name":"the First Affiliated Hospital of Xian Jiaotong University \u00a0 , Shaanxi, Xian , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghao","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Changsha, Hunan , P.R. China"},{"name":"the Third Xiangya Hospital of Central South University \u00a0 , Changsha, Hunan , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Xian, Shaanxi , P.R. China"},{"name":"Xijing Hospital of Air force Military Medical University \u00a0 , Xian, Shaanxi , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"He","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Shaanxi, Xian , P.R. China"},{"name":"the First Affiliated Hospital of Xian Jiaotong University \u00a0 , Shaanxi, Xian , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Shaanxi, Xian , P.R. China"},{"name":"the First Affiliated Hospital of Xian Jiaotong University \u00a0 , Shaanxi, Xian , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,27]]},"reference":[{"key":"2023012008292880500_bib1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jsm.12504","article-title":"An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE)","volume":"11","author":"Althof","year":"2014","journal-title":"J Sex Med"},{"key":"2023012008292880500_bib2","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jsm.12524","article-title":"An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation","volume":"11","author":"Serefoglu","year":"2014","journal-title":"J Sex Med"},{"key":"2023012008292880500_bib3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/aja.2012.108","article-title":"New insights on premature ejaculation: a review of definition, classification, prevalence and treatment","volume":"14","author":"Serefoglu","year":"2012","journal-title":"Asian J Androl"},{"key":"2023012008292880500_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/aja.2010.135","article-title":"Male sexual dysfunction in Asia","volume":"13","author":"Ho","year":"2011","journal-title":"Asian J Androl"},{"key":"2023012008292880500_bib5","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1743-6109.2009.01696.x","article-title":"The dopamine transporter gene (DAT1) polymorphism is associated with premature ejaculation","volume":"7","author":"Santtila","year":"2010","journal-title":"J Sex Med"},{"key":"2023012008292880500_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5489\/cuaj.12002","article-title":"Evolving therapeutic strategies for premature ejaculation: The search for on-demand treatment - topical versus systemic","volume":"6","author":"Morales","year":"2012","journal-title":"Can Urol Assoc J"},{"issue":"Suppl 4","key":"2023012008292880500_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1743-6109.2011.02451.x","article-title":"An overview of pharmacotherapy in premature ejaculation","volume":"8","author":"Porst","year":"2011","journal-title":"J Sex Med"},{"key":"2023012008292880500_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1756287211424172","article-title":"Eardley I. Medical therapy for premature ejaculation","volume":"3","author":"Mohee","year":"2011","journal-title":"Ther Adv Urol"},{"key":"2023012008292880500_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/jcpt.12115","article-title":"An improved dosage regimen of sertraline hydrochloride in the treatment for premature ejaculation: an 8-week, single-blind, randomized controlled study followed by a 4-week, open-label extension study","volume":"39","author":"Xu","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"2023012008292880500_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.urology.2013.12.004","article-title":"Comparison of the effect of sertraline with behavioral therapy on semen parameters in men with primary premature ejaculation","volume":"83","author":"Akasheh","year":"2014","journal-title":"Urology"},{"key":"2023012008292880500_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1756287212453866","article-title":"Dapoxetine: a new option in the medical management of premature ejaculation","volume":"4","author":"McMahon","year":"2012","journal-title":"Ther Adv Urol"},{"key":"2023012008292880500_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/CMRH.S7337","article-title":"Efficacy of dapoxetine in the treatment of premature ejaculation","volume":"5","author":"McMahon","year":"2011","journal-title":"Clin Med Insights Reprod Health"},{"key":"2023012008292880500_bib13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1177\/0091270006291033","article-title":"Pharmacokinetics of dapoxetine, a new treatment for premature ejaculation: Impact of age and effects of a high-fat meal","volume":"46","author":"Dresser","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"2023012008292880500_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"key":"2023012008292880500_bib15","doi-asserted-by":"crossref","first-page":"e13854","DOI":"10.1111\/and.13854","article-title":"Comparison of the safety and efficacy of the on-demand use of sertraline, dapoxetine, and daily use of sertraline in the treatment of patients with lifelong premature ejaculation: A prospective randomised study","volume":"52","author":"Sahan","year":"2020","journal-title":"Andrologia"},{"key":"2023012008292880500_bib16","first-page":"892","article-title":"Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation","volume":"21","author":"Yang","year":"2015","journal-title":"Zhonghua Nan Ke Xue"},{"key":"2023012008292880500_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1464-410X.2008.08041.x","article-title":"The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice","volume":"103","author":"Patrick","year":"2009","journal-title":"BJU Int"},{"key":"2023012008292880500_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01541858","article-title":"Rapid ejaculation: a review of conceptual, etiological, and treatment issues","volume":"24","author":"Grenier","year":"1995","journal-title":"Arch Sex Behav"},{"key":"2023012008292880500_bib19","article-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision","author":"American Psychiatric Association","year":"2000"},{"key":"2023012008292880500_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/00926230390224738","article-title":"How does premature ejaculation impact a man's life?","volume":"29","author":"Symonds","year":"2003","journal-title":"J Sex Marital Ther"},{"key":"2023012008292880500_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1743-6109.2004.04033.x","article-title":"Self-reported premature ejaculation and aspects of sexual functioning and satisfaction","volume":"1","author":"Rowland","year":"2004","journal-title":"J Sex Med"},{"key":"2023012008292880500_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.eururo.2013.08.018","article-title":"Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study","volume":"65","author":"Mirone","year":"2014","journal-title":"Eur Urol"},{"key":"2023012008292880500_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Dapoxetine Study Group. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation: Integrated analysis of two randomized, double-blind, placebo-controlled trials","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116121001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116121001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/10\/1\/100473\/48792403\/smoa_10_1_100473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/10\/1\/100473\/48792403\/smoa_10_1_100473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T03:31:54Z","timestamp":1674185514000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/10\/1\/100473\/6956757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,27]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.esxm.2021.100473","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2]]},"published":{"date-parts":[[2021,12,27]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Dapoxetine in the Treatment of Patients With Lifelong Premature Ejaculation as an Alternative to Sertraline Therapy","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esxm.2021.100473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}